About
VerAvanti Inc. is a medical technology company based in Redmond, Washington, specializing in advanced intravascular imaging solutions. The company has developed the Scanning Fiber Endoscope (SaFE) technology, which enhances diagnostic accuracy and safety in fields like cardiology and neurosurgery. With a team of engineering graduates from the University of Washington, VerAvanti holds over 50 U.S. patents and has secured more than $33 million in funding. The core product, the Scanning Fiber Endoscope (SFE), is a single-use, ultrathin device that utilizes advanced scanning laser light technology for high-resolution imaging. This multimodal capability improves visualization of intravascular structures, addressing limitations of traditional imaging methods. VerAvanti aims to enhance patient outcomes by making procedures safer and more effective, with a focus on minimally invasive applications, including early cancer diagnosis and surgical guidance. The company is preparing for FDA approval expected by early 2026, with plans for global market launch thereafter, targeting healthcare providers in interventional cardiology, neurosurgery, and peripheral artery interventions.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2013
-
Total Funding $37040000
Location
22322 20th Ave SE, Bothell, Washington, United States, 98021-8418